NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

NBER Working Papers by John Vernon

Contact and additional information for this authorAll NBER papers and publicationsNBER Working Papers only

Working Papers

February 2010Generic Utilization Rates, Real Pharmaceutical Prices, and Research and Development Expenditures
with Joseph P. Cook, Graeme Hunter: w15723
April 2009What's the "Interest" in FDA Drug Advisory Committee Conflicts of Interest?
with Joseph Golec: w14932
November 2007Financial Risk in the Biotechnology Industry
with Joseph H. Golec: w13604

Published: Appl Health Econ Health Policy. 2009;7(3):155-65. doi: 10.2165/10899620-000000000-00000. Financial risk of the biotech industry versus the pharmaceutical industry.

December 2006Black Box Warnings and Drug Safety: Examining the Determinants and Timing of FDA Warning Labels
with Allan Begosh, John Goldsmith, Ed Hass, Randall W. Lutter, Clark Nardinelli: w12803
November 2006European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending
with Joseph H. Golec: w12676
December 2005The Future of Drug Development: The Economics of Pharmacogenomics
with W. Keener Hughen: w11875

Published: Vernon, J., Hughen K., Trujillo, A. The Future of Drug Development: The Economics of Pharmacogenomics. January 2008, Vol. 1, No. 1, Pages 49-59 Expert Review of Clinical Pharmacology

October 2005Race and Health Disparities Among Seniors in Urban Areas in Brazil
with Antonio J. Trujillo, Laura Rodriguez Wong, Gustavo Angeles: w11690

Published: Trujillo, Antonio J., John A. Vernon, Laura Rodriguez Wong, and Gustavo Angeles. "Race and Health Disparities Among Seniors in Urban Areas in Brazil." Journal of Aging and Health 21, 1 (2009): 3-37.

March 2005Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending
with Joseph Golec, Shantaram Hegde: w11229
Hospital Ownership Mix Efficiency in the US: An Exploratory Study
with Rexford E. Santerre: w11192
February 2005Assessing Consumer Gains from a Drug Price Control Policy in the U.S.
with Rexford Santerre: w11139

Published: Santerre, Rexford E. and John A. Vernon. "Assessing Consumer Gains From A Drug Price Control Policy In The United States," Southern Economic Journal, 2006, v73(1,Jul), 233-245.

The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions
with Thomas A. Abbott: w11114

Published: Thomas A. Abbott & John A. Vernon, 2007. "The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 293-306.

Testing for Ownership Mix Efficiency: The Case of the Nursing Home Industry
with Rexford E. Santerre: w11115

Contact and additional information for this authorAll NBER papers and publicationsNBER Working Papers only

 
Publications
Activities
Meetings
NBER Videos
Data
People
About

Support
National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us